key: cord-0937274-o5i9cr0s
authors: Cano-Ortiz, Antonio; Leiva-Gea, Isabel; Ventosa, Álvaro Sánchez-; González-Cruces, Timoteo; Sánchez-González, José-María; Morales, Pablo; Villarrubia, Alberto
title: Stromal Interstitial Keratitis in a patient with COVID-19
date: 2022-01-06
journal: J Fr Ophtalmol
DOI: 10.1016/j.jfo.2021.11.004
sha: b8aaebffd9215fff718524f819586e3876da4f26
doc_id: 937274
cord_uid: o5i9cr0s

nan

Since the outbreak of coronavirus disease 2019 in December 2019, the number of infections and deaths has increased exponentially. In February 2020, Lu et al. suggested that the ocular surface could be a route of transmission for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), and studies were initiated on the association between the virus and the ocular surface [1] . Zhou et al. demonstrated the presence of SARS-CoV-2 in the conjunctival sac of patients with COVID-19 [2] . In addition, Chen et al. reported an association between conjunctival congestion, the main eye symptom associated with COVID-19, and conjunctivitis, which suggests that SARS-CoV-2 can cause conjunctivitis [3] . Daruich et al. [4] demonstrated that conjunctivitis can be the inaugural manifestation of the COVID-19 infection and their case report illustrates the interest of telemedicine in ophthalmology during the COVID-19 pandemic. Several articles have described ophthalmological conditions, with conjunctivitis or keratoconjunctivitis being the main condition from an ophthalmological perspective. Interstitial keratitis is an inflammatory process of the cornea that can be associated with systemic disease of different etiology. We present the first published case of early-onset bilateral interstitial keratitis in a COVID-19-positive patient.

A 25-year-old female nurse reported initially developing loss of smell and taste, fatigue, and decreased vision. PCR testing for COVID-19 was positive and analytical parameters no suggested activation of the cytokine storm (Leukocytes 7,7 10 3 /L, neutrophils 56,9 % (4,4 10 3 /L), lymphocytes 33,5% (2,6 10 3 /L), monocytes 7,5% 

Conjunctival involvement is the most frequent ophthalmological condition within the manifestations of COVID-19, although other conditions are possible and have been published. Until now, bilateral stromal involvement has not been reported in the literature. According to treatment guidelines for epithelial keratitis, glucocorticoids are generally not recommended for viral punctate epithelial keratitis because they are believed to promote viral replication although some authors as Dongyu Guo et al. [5] found that topical glucocorticoids played an important role in the recovery of keratoconjunctivitis in a patient with COVID-19 and increased local cytokines.

In our case, stromal affectation does not raise doubts about the need for corticosteroid use [6] . In this case, the non-involvement in the cytokine storm, made us opt for topical treatment as the first choice with favorable evolution in just a few days [7] . No slit lamp photograph was taken as the change in stromal density was notorious in the anterior OCT. Stromal keratitis can occur early in patients with COVID-19, in the context of a 

2019-nCoV transmission through the ocular surface must not be ignored

The evidence of SARS-CoV-2 infection on ocular surface

Ocular manifestations and clinical characteristics of 535 cases of COVID-19 in Wuhan, China: a crosssectional study

Ocular manifestation as first sign of Coronavirus Disease 2019 (COVID-19): Interest of telemedicine during the pandemic context

Relapsing viral keratoconjunctivitis in COVID-19: A case report

Update on the Management of Infectious Keratitis

COVID-19): A Review

This manuscript does not include any nonauthor contributors to acknowledge.